Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 1607425, 5 pages
https://doi.org/10.1155/2018/1607425
Research Article

Should We Always Use Antibiotics after Urodynamic Studies in High-Risk Patients?

12nd Department of Gynaecology, Medical University of Lublin, Lublin, Poland
2Department of Urology, Technical University of Munich, Munich, Germany
3Department of Paediatric Pulmonology and Rheumatology, Medical University of Lublin, Lublin, Poland

Correspondence should be addressed to Pawel Miotla; lp.pw@altoimp

Received 5 September 2018; Accepted 22 October 2018; Published 5 November 2018

Guest Editor: Dragana Zivkovic

Copyright © 2018 Pawel Miotla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Gürbüz, B. Güner, G. Atış, L. Canat, and T. Caşkurlu, “Are prophylactic antibiotics necessary for urodynamic study?” Kaohsiung Journal of Medical Sciences, vol. 29, no. 6, pp. 325–329, 2013. View at Publisher · View at Google Scholar
  2. A. M. Suskind, L. Cox, J. Q. Clemens et al., “The Value of Urodynamics in an Academic Specialty Referral Practice,” Urology, vol. 105, pp. 48–53, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. T. Magari, Y. Fukabori, H. Ogura, and K. Suzuki, “Lower urinary tract symptoms of neurological origin in urological practice,” Clinical Autonomic Research, vol. 23, no. 2, pp. 67–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Aoun, A. Peltier, and R. Van Velthoven, “Lower urinary tract dysfunction in pelvic gynecologic cancer: The role of urodynamics,” Advances in Urology, vol. 2014, 2014. View at Google Scholar · View at Scopus
  5. E. Hirakauva, A. Bianchi-Ferraro, E. Zucchi et al., “Incidence of Bacteriuria after Urodynamic Study with or without Antibiotic Prophylaxis in Women with Urinary Incontinence,” Revista Brasileira de Ginecologia e Obstetrícia, vol. 39, no. 10, pp. 534–540, 2017. View at Publisher · View at Google Scholar
  6. G. W. Cundiff, M. T. McLennan, and A. E. Bent, “Randomized Trial of Antibiotic Prophylaxis for Combined Urodynamics and Cystourethroscopy,” Obstetrics & Gynecology, vol. 93, no. 5, pp. 749–752, 1999. View at Publisher · View at Google Scholar
  7. P. M. Latthe, R. Foon, and P. Toozs-Hobson, “Prophylactic antibiotics in urodynamics: A systematic review of effectiveness and safety,” Neurourology and Urodynamics, vol. 27, no. 3, pp. 167–173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Wagenlehner, C. Wagenlehner, S. Schinzel, and K. Naber, “Prospective, Randomized, Multicentric, Open, Comparative Study on the Efficacy of a Prophylactic Single Dose of 500mg Levofloxacin versus 1920mg Trimethoprim/Sulfamethoxazole versus a Control Group in Patients Undergoing TUR of the Prostate,” European Urology, vol. 47, no. 4, pp. 549–556, 2005. View at Publisher · View at Google Scholar
  9. S.-W. Tsai, F.-T. Kung, F.-C. Chuang, Y.-C. Ou, C.-J. Wu, and K.-H. Huang, “Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results,” Taiwanese Journal of Obstetrics and Gynecology, vol. 52, no. 4, pp. 493–497, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Nadeem, M. I. Sheikh, M. S. Sait, N. Emmanuel, M. K. M. Sheriff, and S. Masood, “Is urinary tract infection after urodynamic study predictable?” Urological Science, vol. 28, no. 4, pp. 240–242, 2017. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Nóbrega, A. P. F. Auge, L. G. M. De Toledo, S. Da Silva Carramão, A. B. Frade, and M. J. C. Salles, “Bacteriuria and urinary tract infection after female urodynamic studies: Risk factors and microbiological analysis,” American Journal of Infection Control, vol. 43, no. 10, pp. 1035–1039, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Cameron, L. Campeau, B. M. Brucker et al., “Best practice policy statement on urodynamic antibiotic prophylaxis in the non-index patient,” Neurourology and Urodynamics, vol. 36, no. 4, pp. 915–926, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Foon, P. Toozs-Hobson, and P. Latthe, “Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies.,” Cochrane Database of Systematic Reviews (Online), vol. 10, p. CD008224, 2012. View at Google Scholar · View at Scopus
  14. K. G. Naber, “Efficacy and safety of the phytotherapeutic drug Canephron® N in prevention and treatment of urogenital and gestational disease: Review of clinical experience in Eastern Europe and Central Asia,” Research and Reports in Urology, vol. 5, pp. 39–46, 2013. View at Google Scholar · View at Scopus
  15. R. C. Bump, A. Mattiasson, K. Bo et al., “The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction,” American Journal of Obstetrics & Gynecology, vol. 175, no. 1, pp. 10–17, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Bombieri, D. A. B. Dance, G. W. Rienhardt, A. Waterfield, and R. M. Freeman, “Urinary tract infection after urodynamic studies in women: Incidence and natural history,” BJU International, vol. 83, no. 4, pp. 392–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Z. Almallah, C. D. Rennie, J. Stone, and M. J. R. Lancashire, “Urinary tract infection and patient satisfaction after flexible cystoscopy and urodynamic evaluation,” Urology, vol. 56, no. 1, pp. 37–39, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. J. H. Ku, S. W. Kim, H. H. Kim, J.-S. Paick, H. Son, and S.-J. Oh, “Patient experience with a urodynamic study: A prospective study in 208 patients,” The Journal of Urology, vol. 171, no. 6 I, pp. 2307–2310, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Subramaniam, “Association of Urinary Tract Infection in Married Women Presenting with Urinary Incontinence in a Hospital based Population,” Journal of Clinical and Diagnostic Research, 2016. View at Publisher · View at Google Scholar
  20. P. Miotla, K. Romanek-Piva, M. Bogusiewicz et al., “Antimicrobial Resistance Patterns in Women with Positive Urine Culture: Does Menopausal Status Make a Significant Difference?” BioMed Research International, vol. 2017, 2017. View at Google Scholar · View at Scopus
  21. K. G. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei, “Surveillance study in europe and brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy,” European Urology, vol. 54, no. 5, pp. 1164–1178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. F. M. E. Wagenlehner, U. Hoyme, M. Kaase, R. Fünfstück, K. G. Naber, and G. Schmiemann, “Uncomplicated urinary tract infections,” Deutsches Ärzteblatt International, vol. 108, no. 24, pp. 415–423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. J. L. Lowder, L. J. Burrows, N. L. S. Howden, and A. M. Weber, “Prophylactic antibiotics after urodynamics in women: A decision analysis,” International Urogynecology Journal, vol. 18, no. 2, pp. 159–164, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. U. M. Peschers, V. Kempf, K. Jundt, I. Autenrieth, and T. Dimpfl, “Antibiotic treatment to prevent urinary tract infections after urodynamic evaluation,” International Urogynecology Journal, vol. 12, no. 4, pp. 254–257, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Sundqvist, P. Geli, D. I. Andersson et al., “Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use,” Journal of Antimicrobial Chemotherapy, vol. 65, no. 2, pp. 350–360, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. B. R. Levin, “Minimizing potential resistance: A population dynamics view,” Clinical Infectious Diseases, vol. 33, no. 3, pp. S161–S169, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. K. Shepherd and P. S. Pottinger, “Management of Urinary Tract Infections in the Era of Increasing Antimicrobial Resistance,” Medical Clinics of North America, vol. 97, no. 4, pp. 737–757, 2013. View at Publisher · View at Google Scholar · View at Scopus